Isodeoxyelephantopin (IDET) enhances paclitaxel sensitivity in thyroid cancer by promoting ROS‐mediated apoptosis through inhibition of the p62‐Keap1‐Nrf2 antioxidant pathway. Here, SQSTM1 is linked to thyroid cancer.